Needham & Company Maintains a 'Buy' on Cynosure (CYNO); New Products Highlighted at ASLMS Meetings
Tweet
Share
E-mailGet Alerts CYNO Hot Sheet
Price: $66.00 --0%
Rating Summary:
8 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company maintains a 'Buy' on Cynosure (NASDAQ: CYNO) price target of $22.00.
Analyst, Dalton Chandler, said, "CYNO’s new PicoSure picosecond (10-12 sec pulse duration) Alexandrite (755 nm) laser seemed to be the hottest new product at the 2012 ASLMS meeting. The much shorter pulse duration compared to the previous industry-best nanosecond (10-9 sec) pulse, enables “mechanical” rather than “thermal” damage to targets. This narrow pulse width makes it ideal for small targets, including tattoo pigments. It has been estimated that 40MM Americans currently have tattoos, with about half likely to eventually want them removed. Previously, in our opinion there was no good solution for the removal of complex, multi-colored tattoos."
Needham raises FY12 from $0.18 to $0.36.
For an analyst ratings summary and ratings history on Cynosure click here. For more ratings news on Cynosure click here.
Shares of Cynosure closed at $20.22 yesterday.
Analyst, Dalton Chandler, said, "CYNO’s new PicoSure picosecond (10-12 sec pulse duration) Alexandrite (755 nm) laser seemed to be the hottest new product at the 2012 ASLMS meeting. The much shorter pulse duration compared to the previous industry-best nanosecond (10-9 sec) pulse, enables “mechanical” rather than “thermal” damage to targets. This narrow pulse width makes it ideal for small targets, including tattoo pigments. It has been estimated that 40MM Americans currently have tattoos, with about half likely to eventually want them removed. Previously, in our opinion there was no good solution for the removal of complex, multi-colored tattoos."
Needham raises FY12 from $0.18 to $0.36.
For an analyst ratings summary and ratings history on Cynosure click here. For more ratings news on Cynosure click here.
Shares of Cynosure closed at $20.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Optimum Communications gets NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
